DSGN
Price
$10.37
Change
+$3.25 (+45.65%)
Updated
Feb 3 closing price
Capitalization
590.14M
41 days until earnings call
Intraday BUY SELL Signals
VRDN
Price
$31.90
Change
+$10.09 (+46.26%)
Updated
Feb 3 closing price
Capitalization
3.04B
29 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

DSGN vs VRDN

Header iconDSGN vs VRDN Comparison
Open Charts DSGN vs VRDNBanner chart's image
Design Therapeutics
Price$10.37
Change+$3.25 (+45.65%)
Volume$148.79K
Capitalization590.14M
Viridian Therapeutics
Price$31.90
Change+$10.09 (+46.26%)
Volume$1.57M
Capitalization3.04B
DSGN vs VRDN Comparison Chart in %
DSGN
Daily Signal:
Gain/Loss:
VRDN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
DSGN vs. VRDN commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DSGN is a Hold and VRDN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (DSGN: $10.37 vs. VRDN: $31.90)
Brand notoriety: DSGN and VRDN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DSGN: 37% vs. VRDN: 106%
Market capitalization -- DSGN: $590.14M vs. VRDN: $3.04B
DSGN [@Biotechnology] is valued at $590.14M. VRDN’s [@Biotechnology] market capitalization is $3.04B. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DSGN’s FA Score shows that 0 FA rating(s) are green whileVRDN’s FA Score has 0 green FA rating(s).

  • DSGN’s FA Score: 0 green, 5 red.
  • VRDN’s FA Score: 0 green, 5 red.
According to our system of comparison, VRDN is a better buy in the long-term than DSGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DSGN’s TA Score shows that 4 TA indicator(s) are bullish while VRDN’s TA Score has 1 bullish TA indicator(s).

  • DSGN’s TA Score: 4 bullish, 3 bearish.
  • VRDN’s TA Score: 1 bullish, 6 bearish.
According to our system of comparison, DSGN is a better buy in the short-term than VRDN.

Price Growth

DSGN (@Biotechnology) experienced а -2.08% price change this week, while VRDN (@Biotechnology) price change was -4.89% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.22%. For the same industry, the average monthly price growth was +3.03%, and the average quarterly price growth was +35.17%.

Reported Earning Dates

DSGN is expected to report earnings on Mar 17, 2026.

VRDN is expected to report earnings on Mar 05, 2026.

Industries' Descriptions

@Biotechnology (-4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VRDN($3.05B) has a higher market cap than DSGN($590M). DSGN YTD gains are higher at: 10.554 vs. VRDN (2.506). DSGN has higher annual earnings (EBITDA): -77.38M vs. VRDN (-298.48M). VRDN has more cash in the bank: 491M vs. DSGN (206M). DSGN has less debt than VRDN: DSGN (1.74M) vs VRDN (21.6M). VRDN has higher revenues than DSGN: VRDN (70.8M) vs DSGN (0).
DSGNVRDNDSGN / VRDN
Capitalization590M3.05B19%
EBITDA-77.38M-298.48M26%
Gain YTD10.5542.506421%
P/E RatioN/AN/A-
Revenue070.8M-
Total Cash206M491M42%
Total Debt1.74M21.6M8%
FUNDAMENTALS RATINGS
VRDN: Fundamental Ratings
VRDN
OUTLOOK RATING
1..100
5
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
PROFIT vs RISK RATING
1..100
64
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DSGNVRDN
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
74%
Momentum
ODDS (%)
Bullish Trend 1 day ago
89%
Bearish Trend 1 day ago
82%
MACD
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 9 days ago
89%
Bullish Trend 8 days ago
82%
Declines
ODDS (%)
Bearish Trend 20 days ago
84%
Bearish Trend 6 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
78%
Aroon
ODDS (%)
Bullish Trend 1 day ago
87%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
DSGN
Daily Signal:
Gain/Loss:
VRDN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
COVUX14.790.17
+1.16%
Columbia Overseas Value R
VRSCX28.060.03
+0.11%
Voya SmallCap Opportunities Port R6
BALSX9.67N/A
N/A
BlackRock U.S. Insights Lon/Shr Eq Inv A
BIASX19.87-0.15
-0.75%
Brown Advisory Small-Cap Growth Inv
GRISX31.08-0.27
-0.86%
Nationwide S&P 500 Index Instl Svc

DSGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DSGN has been loosely correlated with IDYA. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if DSGN jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DSGN
1D Price
Change %
DSGN100%
-0.38%
IDYA - DSGN
51%
Loosely correlated
+0.50%
DYN - DSGN
51%
Loosely correlated
+1.07%
SLDB - DSGN
50%
Loosely correlated
+1.71%
SYRE - DSGN
49%
Loosely correlated
+1.65%
VRDN - DSGN
49%
Loosely correlated
-3.92%
More

VRDN and

Correlation & Price change

A.I.dvisor indicates that over the last year, VRDN has been loosely correlated with SYRE. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if VRDN jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRDN
1D Price
Change %
VRDN100%
-3.92%
SYRE - VRDN
57%
Loosely correlated
+1.65%
NUVL - VRDN
57%
Loosely correlated
+2.12%
OCUL - VRDN
52%
Loosely correlated
-6.99%
AGIO - VRDN
52%
Loosely correlated
-0.82%
CRNX - VRDN
52%
Loosely correlated
+1.24%
More